Insider Transactions in Q1 2026 at Ultragenyx Pharmaceutical Inc. (RARE)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Howard Horn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,150
-3.31%
|
$69,300
$22.84 P/Share
|